tiprankstipranks
IGC Pharma (DE:IGS1)
FRANKFURT:IGS1
Holding DE:IGS1?
Track your performance easily

IGC Pharma (IGS1) Cash flow

6 Followers

IGC Pharma Cash Flow

DE:IGS1's free cash flow for Q2 2025 was $-1.06M. For the 2025 fiscal year, DE:IGS1's free cash flow was decreased by $1.46M and operating cash flow was $-996.00K. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Operating Cash Flow
$ -5.80M$ -5.20M$ -7.05M$ -7.46M$ -10.80M$ -8.68M
Investing Cash Flow
$ -262.00K$ -317.00K$ -235.00K$ -742.00K$ 3.39M$ -9.55M
Financing Cash Flow
$ 3.30M$ 3.52M$ 100.00K$ 4.14M$ 14.69M$ -59.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 6.47M$ 1.20M$ 3.20M$ 10.46M$ 14.55M$ 7.26M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-----$ 8.00K
Issuance Of Capital Stock
$ 3.30M$ 3.53M$ 103.00K$ 4.14M$ 14.16M$ -59.00K
Issuance Of Debt
$ -4.00K$ -3.00K$ -3.00K$ -3.00K$ 530.00K-
Repayment Of Debt
------
Free Cash Flow
$ -6.09M$ -5.67M$ -7.13M$ -8.20M$ -12.39M$ -13.14M
Domestic Sales
------
Foreign Sales
------
Currency in USD

IGC Pharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis